Aortic valve stenosis (AVS) is a significant health concern affecting over 1.5 million Americans and millions more globally. Researchers are exploring the use of a new drug called ataciguat to manage AVS. Results from preclinical and clinical studies show that ataciguat has the potential to significantly slow disease progression.
Read more …New drug may reduce need for aortic valve surgeries by slowing disease progression